Last reviewed · How we verify

NCT05341596

Incidence and Outcome of Reintubation in the PACU

Completed Last updated 22 April 2022
What this trial tests

trial testing repeat endotracheal intubation in Postoperative Complications in 121,965 participants. Completed in 1 October 2020.

Timeline
1 January 2020
Primary endpoint
31 August 2020
1 October 2020

Quick facts

Lead sponsorShangkun Liu (200966)
StatusCompleted
Study typeOBSERVATIONAL
Enrollment121,965
Start date1 January 2020
Primary completion31 August 2020
Estimated completion1 October 2020

Drugs / interventions tested

Conditions studied

Sponsor

Shangkun Liu (200966)

Who can join

Eligibility, any sex, with Postoperative Complications or Complication of Medical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluated the occurrence of reintubation after planned extubation (RAP), the impact of RAP on duration of PACU stay,length of stay,length of postoperative stay,inpatient healthcare costs, unanticipated ICU admission and readmission.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Complications

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05341596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing